| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |